Parkinson’s Disease

2 months ago | acnr.co.uk | Movement Disorders |Parkinson’s Disease

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson’s disease. Researchers identified genetic factors in progression and FDA-approved drugs that can potentially be repurposed for PD treatment.

Nov 13, 2024 | express-press-release.net | Parkinson’s Disease

California, 2024-Nov-13 — /EPR Network/ —Recently published study by Prophecy Market Insights Bioelectric Medicine Market Size, Share & Trends Outlook Report [2024-2034] contains a detailed examination of major trends, dynamics, and market size of Bioelectric Medicine market. The market has many participants, each with their own product description, classification, and industrial structure.

Oct 1, 2024 | madamenoire.com | Parkinson’s Disease |Shannon Dawson

MadameNoire Featured Video In a recent speech, Viola Davis discussed her childhood marked by extreme poverty and racial discrimination. Despite these obstacles, she emphasized that these “dark” experiences only strengthened her determination to achieve greatness.

May 13, 2024 | ptproductsonline.com | Melanie Hamilton-Basich |Parkinson’s Disease

It’s one of the inescapable realities of aging: The older we get, the slower we tend to move—whether we’re walking around the block or just reaching for the remote control. A new study led by the University of Colorado Boulder (CU Boulder) engineers helps explain why. The research is one of the first studies to experimentally tease apart the competing reasons why people over age 65 might not be as quick on their feet as they used to be.

Mar 5, 2024 | ptproductsonline.com | Melanie Hamilton-Basich |Parkinson’s Disease

More than 5 million people worldwide are living with neurodegenerative disorders like Parkinson’s disease and primary progressive multiple sclerosis (PPMS). Researchers funded by the National Stem Cell Foundation (NSCF) are turning to the microgravity environment of the International Space Station (ISS) to better understand and model what causes these debilitating diseases as part of an ISS National Laboratory-sponsored investigation flying on Axiom Space’s third private astronaut mission.